A
Arcellx D
D
ACLX
90.370
USD
3.31
(3.80%)
Market Closed
Volume
8,573
EPS
-2
Div Yield
-
P/E
-127
Market Cap
4,886,727,928
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Arcellx
Sector: Healthcare
Industry: Biotechnology
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.